The yellow fever 17D vaccine and risk of malignant melanoma in the United States military

Vaccine
Meredith Hodges-VazquezPatrick Garman

Abstract

Previous studies show that the tuberculosis and smallpox vaccine protect against melanoma because of sequence homologies they have with the melanoma antigen, HERV-K-MEL. The yellow fever 17D (YF 17D) vaccine is thought to have this property, so there is a possibility that the YF17D vaccine is able to protect against melanoma. This nested case-control study used the Defense Medical Surveillance System to assess the association between the YF17D vaccine and risk of malignant melanoma in active members of the United States military. Although point estimates hinted at a protective effect, none of the values reached a significant level. Therefore, this study concluded that in the ten year period following vaccination there is no association between the yellow fever 17D vaccine and risk of malignant melanoma in active members of the US armed forces.

References

Jul 10, 2002·Acta Oncologica·Eva Månsson-BrahmeUlrik Ringborg
Sep 17, 2002·The Journal of Investigative Dermatology·Annette PfahlbergOlaf Gefeller
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Alan C GellerHoward K Koh
Jun 26, 2003·JAMA : the Journal of the American Medical Association·John D Grabenstein, William Winkenwerder
Oct 15, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B KroneA Pfahlberg
Nov 3, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Esther de Vries, Jan Willem Coebergh
Dec 25, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Bernd KroneJohn M Grange
Dec 25, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K F KölmelA Pfahlberg
Jun 1, 2005·Journal of Cutaneous Medicine and Surgery·Marcie J UlmerPeter R Hull
Dec 13, 2006·The Journal of Allergy and Clinical Immunology·Janie Parrino, Barney S Graham
Nov 18, 2008·Vaccine·G MastrangeloK F Koelmel
Dec 20, 2008·Clinics in Dermatology·Claus Garbe, Ulrike Leiter
Jan 10, 2009·The Journal of Investigative Dermatology·Eleni LinosChristina A Clarke
Jun 10, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kangmin ZhuKatherine A McGlynn

❮ Previous
Next ❯

Citations

Jan 4, 2013·BMC Cancer·Luca CegolonGiuseppe Mastrangelo
Dec 23, 2015·Assay and Drug Development Technologies·Hermann A M Mucke
Jun 4, 2014·International Journal of Cancer. Journal International Du Cancer·Ronan F DowneySharon A Glynn
Nov 22, 2016·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Giuseppe MastrangeloUgo Fedeli
Mar 30, 2018·Frontiers in Microbiology·Nicole Grandi, Enzo Tramontano
Jun 1, 2021·Frontiers in Oncology·Liese VandeborneGauthier Bouche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.